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Abstract
Background: Physical inactivity is an independent risk factor for diabetes and heart disease. There
is evidence that increasing physical activity can reduce the risk of developing these chronic diseases,
but less evidence about effective ways to increase adherence to physical activity. Interventions are
therefore needed that produce sustained increases in adherence to physical activity, are cost-
effective and improve clinical endpoints.
Methods: The Women's Lifestyle Study is a two year randomized controlled trial involving a
nurse-led intervention to increase physical activity in 40–74 year old physically inactive women
recruited from primary care. Baseline measures were assessed in a face-to-face interview with a
primary care nurse. The intervention involved delivery of a 'Lifestyle script' by a primary care nurse
followed by telephone counselling for nine months and a face-to-face nurse visit at six months.
Outcome measurements are assessed at 12 and 24 months. The primary outcome is physical
activity measured using a validated physical activity questionnaire. Secondary outcomes include
blood pressure, weight, waist circumference, physical fitness (step test), serum HbA1c, fasting
glucose, lipids, insulin, and quality of life (SF36). Costs were measured prospectively to allow a
subsequent cost-effectiveness evaluation if the trial is positive.
Discussion: Due to report in 2008, the Women's Lifestyle Study tests the effectiveness of an
enhanced low-cost, evidence-based intervention in increasing physical activity, and improving
cardiovascular and diabetes risk indicators over two years. If successful in demonstrating
improvements in health outcomes, this randomized controlled trial will be the first to demonstrate
long-term cardiovascular and diabetes risk health benefit, in addition to improvements in physical
activity, from a sustainable physical activity intervention based in primary care.
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Published: 23 July 2007
BMC Public Health 2007, 7:166 doi:10.1186/1471-2458-7-166
Received: 20 December 2006
Accepted: 23 July 2007
This article is available from: http://www.biomedcentral.com/1471-2458/7/166
© 2007 Rose et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Public Health 2007, 7:166 http://www.biomedcentral.com/1471-2458/7/166
Page 2 of 7
(page number not for citation purposes)
Background
Physical inactivity is a major independent risk factor for
type 2 diabetes and cardiovascular disease [1]. Evidence
suggests 30 minutes of moderate intensity physical activ-
ity on most days, or 150 minutes per week is adequate for
health benefit [2]. Fewer than 40% of New Zealand adults
achieve this amount [3]. The sedentary nature of the pop-
ulation, together with the increasing levels of obesity have
contributed to an epidemic of type 2 diabetes in New Zea-
land and internationally [4]. In New Zealand there are
marked disparities in health outcomes for Maori who are
the indigenous people of New Zealand (14% of the pop-
ulation) and Pacific people compared with non-Maori
[5]. For example, Maori and Pacific people are three times
more likely to develop type 2 diabetes than European
New Zealanders [6].
Three randomized controlled trials have demonstrated
that increasing physical activity to recommended levels
and reducing weight can reduce the progression from pre-
diabetes to diabetes by approximately 60% [7-9]. How-
ever, interventions such as those used in the US Diabetes
Prevention Program that involved both dietary and exer-
cise components, are too expensive to be practical from a
population perspective. Evaluations of interventions to
promote physical activity alone have achieved moderate
increases in self-reported physical activity as well as
improved cardio-respiratory fitness in sedentary popula-
tions [10].
'Exercise on prescription' interventions have been used
with some success [11]. For example the 'green prescrip-
tion' is a primary health care program implemented
throughout New Zealand that involves a health profes-
sional's verbal and written advice to a patient to be phys-
ically active, and three months of telephone support from
exercise specialists [12]. A cluster randomized controlled
trial demonstrated that the green prescription interven-
tion produced significant improvements in physical activ-
ity levels and quality of life amongst 40–79 year old 'less
active' adults in primary care over a 12 month period [12].
The proportion of participants that were achieving at least
150 minutes of moderate- or vigorous-intensity leisure
activity increased in the intervention group from 18% to
33% over the 12 months [12]. Despite being cost-effec-
tive, the incremental increase in adherence to physical
activity in those receiving the green prescription was low
(10%) compared with the control group, and did not
demonstrate significant changes in clinical indices
[13,14]. There were trends towards reduced systolic and
diastolic blood pressure and total cholesterol levels,
which were potentially clinically significant across a pop-
ulation [15]. In fact, few long-term evaluations of physical
activity interventions have demonstrated improvements
in clinical risk indices corresponding with increases in
physical activity. A systematic review of interventions to
promote walking found only two studies that achieved
increases in both walking and changes in clinical risk fac-
tors [16]. One study involved participants with Type 2 dia-
betes and demonstrated reduced waist measurements
[17]. Another study involved participants with established
ischemic heart disease and showed improvements in
blood pressure control and cholesterol lowering overall
[18], but neither study demonstrated differences between
intervention and control groups.
Reductions in risk factors for diabetes and cardiovascular
disease may be achieved by greater adherence to physical
activity. Qualitative analyses have indicated that more fol-
low-up and support may improve adherence over time
[19], but little is known about the sustainability of
changes, as few trials have followed participants for more
than 12 months. Those studies that did found few incre-
mental differences at two years, partly due to the lack of a
true control group [20]. The Women's Lifestyle Study was
therefore designed using an existing cost-effective inter-
vention, with extended patient support (nine months,
instead of three months with a basic green prescription)
and the addition of a face-to-face meeting with the nurse
prescriber at six months. The trial has a longer follow-up
than previous trials (two years), measures changes in clin-
ical endpoints as well as change in physical activity and
will assess cost-effectiveness.
Methods
Aim
This randomized controlled trial was designed to assess
the effectiveness of a primary care physical activity pro-
gram in increasing adherence to physical activity and
reducing diabetes and cardiovascular risk among physi-
cally inactive women over a two year period.
Study population
Inclusion criteria included women aged 40–74 years
undertaking less than 150 minutes of at least moderate
intensity physical activity per week. Physical activity status
was determined by asking a single-item physical activity
screening question "As a rule, do you do at least half an
hour of moderate or vigorous exercise (such as walking or
a sport) on five or more days of the week?" This question
has been shown to be highly predictive of low levels of
physical activity [21].
Exclusion criteria were based on recommended contrain-
dications to advising physical activity to older adults and
included presence of unstable angina, uncontrolled con-
gestive heart failure, unstable arrhythmia or heart valvular
disease, progressive or debilitating medical conditions,
and severe hypertension (systolic ≥ 200, or diastolic ≥
120) [22]. The physical activity readiness questionnaireBMC Public Health 2007, 7:166 http://www.biomedcentral.com/1471-2458/7/166
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(PAR-Q) was used to assess whether individuals had any
medical conditions that might be adversely affected by
increasing their physical activity [23]. Individuals with
moderate hypertension (average of three recordings systo-
lic ≥ 170, or diastolic ≥ 100), selected heart, joint or bal-
ance problems were referred to their family physician for
clearance as being safe to undertake moderate intensity
physical activity (such as brisk walking) before being ran-
domized at a subsequent visit.
Recruitment process
Recruitment to the Women's Lifestyle Study took place
between November 2004 and November 2005 from 17
primary care practices. Participants were recruited from
two sources. The first source was an existing cohort of 50–
74 year old women recruited between 1999 and 2002
from 10 primary care practices in Wellington the capital
city of New Zealand [24]. The remainder of the partici-
pants were 50–70 year old women (40–60 years for Maori
and Pacific women) recruited from 13 primary care prac-
tices (including 6 practices from which the first group
were recruited) in 2004–2005, including two Maori
health clinics based on traditional meeting houses
(marae) in Wellington. Family physicians at participating
practices were asked to identify women in the age group
from their practice register excluding patients deemed
inappropriate for participation in a physical activity trial.
Letters were sent from the practice to those identified as
suitable, inviting them to participate in the study. The
invitation letter requested that women contact the
research team if interested in learning more about the
study, using the reply slip and pre-paid envelope sup-
plied. Replies were followed by a phone call from a
research nurse to determine eligibility and invite women
to an interview. Interviews were held at one of six commu-
nity healthcare settings.
Randomisation
Random sequence generation was computer-generated by
an independent researcher using STATA 9.1 (StataCorp,
College Station, TX, USA) in random blocks sized 2 to 10.
Allocation concealment was maintained until after writ-
ten consent and baseline measures were complete.
Sequentially numbered opaque envelopes contained the
allocation of treatment groups (intervention or control)
and were opened by the nurse after baseline measures
were complete.
Control group
Control participants were told they would have their
health followed over the next two years to observe
changes over time. They received usual care from their pri-
mary care practice.
Intervention
The Lifestyle script
The basic green prescription is prescribed by family physi-
cians and practice nurses and involves the provision of tel-
ephone-facilitated activity counselling by community-
based Regional Sports Trusts (RST) and their exercise spe-
cialists over a three month period [25]. This study used an
enhanced green prescription (referred to in this trial as a
'Lifestyle script') that included telephone support from an
RST exercise specialist over a nine month period, and
involved a face-to-face visit with the primary care nurse at
six months to monitor progress and to provide additional
support.
Following the completion of baseline measures, partici-
pants in the intervention group were given a 'Lifestyle
script' that recommended moderate intensity brisk walk-
ing (for most participants) or equivalent at a duration and
frequency suitable for the individual participant. The
script was completed with the participants contact details,
as well as clinical details including age, weight, height,
waist circumference, smoking status and any relevant
medical conditions. The script was faxed to the local RST
where a trained exercise specialist with experience in the
'motivational interviewing' counselling technique [26]
provided support to participants over the telephone by
assisting with choice of activity and the development of an
activity plan to fit their lifestyle, goal setting, and ways to
overcome personal barriers to physical activity. Ongoing
support was provided to participants over a nine month
period to help achieve these goals.
Six month visit
At six months, intervention participants received a 30
minute face-to-face interview with a primary care research
nurse. This meeting was used as an opportunity to estab-
lish whether the participant had increased her physical
activity to the target level (30 minutes of moderate or vig-
orous physical activity on five or more days of the week),
and was also an opportunity for the nurse to provide
encouragement and motivation, and discuss personal
health benefits of physical activity. The nurse was pro-
vided with a written progress report by the exercise spe-
cialist, for use as a discussion tool at the six month visit.
Blood pressure, weight and waist were measured and feed-
back on changes from baseline given to the women. Infor-
mation on physical activity, tools to assist with choosing
appropriate types of activities and motivational aids, such
as fridge magnets and activity record charts were also
offered.
Blinding – single blind
Baseline measures were taken prior to allocation of ran-
domisation. Nurses assessing participants at 12 and 24
month follow-up visits were blind to the allocation ofBMC Public Health 2007, 7:166 http://www.biomedcentral.com/1471-2458/7/166
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treatment group. Participants were asked not to discuss
group allocation with the assessing nurse.
Outcome measures
Study measures were assessed at baseline, 12 and 24
months. The primary outcome measure was physical
activity as assessed by the New Zealand physical activity
questionnaire long form (NZPAQ-LF) [27]. The NZPAQ-
LF is a validated questionnaire that asks participants
about physical activity carried out in the past seven days
in relation to activity type, context, intensity and duration.
Secondary outcomes include: fasting serum HbA1c, lip-
ids, glucose and insulin; weight; waist circumference;
blood pressure; physical fitness (measured using a step
test) and quality of life (SF36) [28]. Demographic and
health data were also collected.
Data management and quality assurance
Data were entered directly into a customized Microsoft
Access database by research nurses at the time of the inter-
view. Daily backups were performed and transferred to
the master database at least weekly. Random checks of
data entry were performed regularly and corrections made
where possible by checking against paper records or in
rare cases by phoning participants for confirmation. Clin-
ical recordings outside the normal range were flagged for
confirmation of value. All blood samples were tested at
the same IANZ accredited laboratory.
Sample size
On the basis of means, standard deviations and achieved
levels of physical activity from previous trials, a sample
size of 880 participants was required to detect a minimum
of 7% change in the proportion of women reaching the
target level of 150 minutes of moderate- or vigorous-
intensity physical activity per week, allowing for a 10%
attrition rate (α = 0.05, 80% power) [12,29]. This sample
size will also be adequate to detect as statistically signifi-
cant, a difference between the groups in secondary out-
comes of 3 mmHg diastolic blood pressure, 0.25 mmol/L
serum cholesterol, 0.1 mmol/L HDL and 0.2% HbA1c.
Statistical methods
Descriptive statistics will be calculated and intervention
and control groups checked for balance in demographic,
health and outcome measures at baseline. Final analyses
will be undertaken using generalized linear mixed models
to investigate changes over time in the two groups in the
major outcomes. These models allow for repeated meas-
ures and can be used for normally distributed, binomial,
and ordinal data. An intention-to-treat analysis of all par-
ticipants enrolled in the study will be carried out accord-
ing to allocation of randomization, regardless of physical
activity adherence. Analyses will commence when all 24
month study measures have been completed so data col-
lection remains blind to any trends in effectiveness until
all data is collected.
Cost-effectiveness analysis
Cost components of the intervention are recorded pro-
spectively from a health-funder and patient perspective.
This data will be used in a subsequent cost effectiveness
analysis, should the trial prove positive.
Discussion
Due to report in 2008, the Women's Lifestyle Study tests
the effectiveness and sustainability of an enhanced low-
cost, evidence-based intervention in increasing physical
activity, and improving cardiovascular and diabetes risk
indicators over two years. If successful in demonstrating
improvements in health outcomes, this randomized con-
trolled trial will be the first to demonstrate long-term car-
diovascular and diabetes risk health benefit, in addition to
improvements in physical activity, from a sustainable
physical activity intervention based in primary care.
Primary health care is an ideal setting to identify adults
who are physically inactive and to initiate a brief, cost-
effective physical activity intervention. Over 80% of
female adults visit their primary care provider (family
physician or primary care nurse) each year [30]. Risk fac-
tors for diabetes and cardiovascular disease are assessed in
primary care and people are used to receiving health-
related messages in the context of primary health care.
Furthermore, the basic green prescription program is
already disseminated throughout New Zealand, delivered
to nearly 16,000 patients per year [31]. If the present trial
is positive, the data will be assessed to determine whether
the enhanced program is cost-effective.
A strength of this study is the inclusion of indigenous
Maori, as well as Pacific women who are at greater risk for
the development of diabetes in New Zealand. A limitation
of the trial is the possibility that participants in the control
group are given a basic green prescription as part of their
usual care. This potential contamination may dilute the
effect of the intervention. However, in a previous trial, the
percentage of those in the control group that received a
green prescription as part of their usual care was less than
3% so levels of contamination are likely to be low [12]. If
successful, this relatively simple intervention delivered
through primary care will improve risk factors for cardio-
vascular disease and diabetes in mid-life and older
women, and has the potential to be delivered with success
to other sedentary population groups.
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